Cytogenetic Abnormalities in Natural Killer Cell LymphomaLeukaemia - Is There a Consistent Pattern?

References

• Mitelman F. Catalog of Chromosome Aberrations in Cancer. Wiley-Liss, New York 1991; 4, th edn
   Google Scholar
• Harris N. L., Jaffe E. S., Stein H., Banks P. M., Chan J. K.C., Cleary M. L., Delsol G., De Wolf-Peeters C., Falini B., Gatter K. C., Grogan T. M., Isaacson P. G., Knowles D. M., Mason D. Y., Muller-Hemelink H., Pileri S. A., Pins M. A., Ralfkiaer E., Wamke R. A. A revised European-American Classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–1392
   PubMed Web of Science ®Google Scholar
• Kern W. F., Spier C. M., Hanneman E. H., Miller T. P., Matzner M., Grogan T. M. Neural cell adhesion molecule-positive peripheral T-cell lymphoma: a rare variant with a propensity for unusual sites of involvement. Blood 1992; 79: 2432–2437
   PubMed Web of Science ®Google Scholar
• Wong K. F., Chan J. K.C., Ng C. S., Lee K. C., Tsang W. Y.W., Cheung M. M.C. CD56 (NKH1)-positive hematolymphoid malignancies: an aggressive neoplasm featuring frequent cutaneoushnucosal involvement, cytoplasmic azurophilic granules and angiocentricity. Human Pathology 1992; 23: 798–804
   PubMed Web of Science ®Google Scholar
• Chan J. K.C., Sin V. C., Wong K. F., Ng C. S., Tsang W. Y.W., Chan C. H., Cheung M. M.C., Lau W. H. Non-nasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 1997; 89: 4501–4513
   PubMed Web of Science ®Google Scholar
• Kwong Y. L., Chan A. C.L., Liang R., Chiang A. K.S., Chim C. S., Chan T. K. CD56+ NK lymphomas: clinicopathologic features and prognosis. British Journal of Haematology 1997; 97: 821–829
   PubMed Web of Science ®Google Scholar
• Cheung M. M.C., Chan J. K.C., Lau W. H., Foo W., Chan P. T., Ng C. S., Ngan R. K.C. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features. tumor immunophenotype, and treatment outcome in 113 patients. Journal of Clinical Oncology 1998; 16: 70–77
   Google Scholar
• Chan J. K.C., Tsang W. Y.W., Ng C. S., Pau M. Y. Discordant CD3 expression in lymphomas when studied on frozen and paraffin sections. Human Pathology 1995; 26: 1139–1143
   PubMed Web of Science ®Google Scholar
• Emile J., Boulland M., Haioun C., Kanavaros P., Petrella T., Delfau-Larue M., Bensussan A., Farcet J., Gaulard P. CD5– CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas. Blood 1996; 87: 1466–1473
   PubMed Web of Science ®Google Scholar
• Tsang W. Y.W., Chan J. K.C., Yip T. T.C., Ng C. S., Wong K. F., Poon Y. F., Ma V. W.S. In situ localization of Epstein-Ban virus encoded RNA in non-nasahasopharyngeal CD56-positive and CD56-negative T-cell lymphomas. Human Pathology 1994; 25: 758–765
   PubMed Web of Science ®Google Scholar
• Chan J. K.C. Natural killer cell neoplasms. 1998, ASCP Reviews in Pathology (Anatomic Pathology) (in press).
   Google Scholar
• Digiuseppe J. A., Louie D. C., Williams J. E., Miller D. T., Griffin C. A., Mann R. B., Borowitz M. J. Blastic natural killer cell leukemiailymphoma: a clinicopathologic study. American Journal of Surgical Pathology 1997; 21: 1223–1230
   PubMed Web of Science ®Google Scholar
• Sheridan W., Winton E. F., Chan W. C., Gordon D. S., Volger W. R., Phillips C., Bongiovanni K. F., Waldmann T. A. Leukemia of non-T lineage natural killer cells. Blood 1988; 72: 1701–1707
   PubMed Web of Science ®Google Scholar
• Gelb A., Van De Rijn M., Regula D. P., Cornbleet J. P., Kamel I., Horoupian D. S., Clew M. L., Wamke R. A. Epstein-Barr virus-associated natural killer-large granular lymphocyte leukemia. Human Pathology 1994; 25: 953–960
   PubMed Web of Science ®Google Scholar
• Shimodaira S., Ishida F., Kobayashi H., Mahbub B., Kawa-Ha K., Kitano K. The detection of clonal proliferation in granular lymphocyte-proliferative disorders of natural killer cell lineage. British Journal of Haematology 1995; 90: 578–584
   PubMed Web of Science ®Google Scholar
• Ho F. C.S., Srivastava G., Loke S. L., Fu K. H., Leung B. P., Liang R., Choy D. Presence of Epstein-Barr virus DNA in nasal lymphomas of B and “T” cell type. Hemato-logical Oncology 1990; 8: 271–281
   PubMed Web of Science ®Google Scholar
• Medeiros L. J., Jaffe E. S., Chen Y. Y., Weiss L. M. Localization of Epstein-Barr viral genomes in angiocentric immunoproliferative lesions. American Journal of Surgical Pathology 1992; 16: 439–447
   PubMed Web of Science ®Google Scholar
• Tefferi A., Greipp P. R., Leibson P. J., Thibodeau S. N. Demonstration of clonality. by X-linked DNA analysis, in chronic natural killer cell lymphocytosis and successful therapy with oral cyclophosphamide. Leukemia 1992; 6: 477–480
   Google Scholar
• Kelly A., Richards S. J., Sivakumaran M., Shiah C., Stewart A. D., Roberts B. E., Scott C. S. Clonality of CD3 negative large granular lymphocyte proliferations determined by PCR based X-inactivation studies. Journal of Clinical Pathology 1994; 47: 399–404
   PubMed Web of Science ®Google Scholar
• Tien H., Su I., Tang J., Liu M., Lee F., Chen Y., Chuang S. Clonal chromosomal abnormalities as direct evidence for clonality in nasal Thatural killer cell lymphoma. British Journal of Haematology 1997; 97: 621–625
   PubMed Web of Science ®Google Scholar
• Wong K. F., Chan J. K.C., Kwong Y. L. Identification of de1(6)(q21q25) as a recurring chromosomal abnormality of putative NK cell lymphorndeukaernia. British Journal of Haematology 1997; 98: 922–926
   PubMed Web of Science ®Google Scholar
• Hamsons C. J. The lymphomas and chronic lym-phoproliferative disorders. Human Cytogenetics: A Practical Approach, D. E. Rooney, B. H. Czepulkowski. Oxford University Press, Oxford 1992; vol II
   Google Scholar
• Taniwaki M., Tagawa S., Nishigaki H., Horiike S., Mis-Awa S., Shimazaki C., Maekawa T., Fujii H., Kitani T., Abe T. Chromosomal abnormalities define clonal proliferation in CD3– large granular lymphocyte leukemia. American Journal of Hematology 1990; 33: 32–38
   PubMed Web of Science ®Google Scholar
• Hoshino S., Oshirni K., Tsudo M., Miyasaka M., Teramure M., Masuda M., Motoji T., Mizoguchi H. Flow cytometric analysis of expression of interleukin-2 receptor β chain (p70–75) on various leukemic cells. Blood 1990; 76: 767–774
   PubMed Web of Science ®Google Scholar
• Phillips J. H., Lanier L. L. Dissection of the lymphokine-activated killer phenomenon: relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis. Journal of Experimental Medicine 1986; 164: 814–825
   PubMed Web of Science ®Google Scholar
• Tsudo M., Goldman C. K., Bongiovanni K. F., Chan W. C., Winton E. F., Yagiat M., Grimm E. A., Waldmann T. A. The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells. Proceedings of the National Academy of Science USA 1987; 84: 5394–5398
   PubMed Web of Science ®Google Scholar
• Imamura N., Kusunoki Y., Kawa-Ha K., Yumura K., Hara J., Oda K., Abe K., Dohy H., Inada T., Kajihara H., Kuramoto A. Aggressive natural killer cell leu-kaemiaflymphoma: report of four cases and review of the literature. British Journal of Haematology 1990; 75: 49–59
   PubMed Web of Science ®Google Scholar
• Nakamura S., Suchi T., Koshikawa T., Kitoh K., Koike K., Komatsu H., Iida S., Kagami Y., Ogura M., Katoh E., Kurita S., Suzuki H., Kobashi Y., Yamabe H., Hirabayashi N., Ueda R., Takahashi T. Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occumng in sites other than the upper and lower respiratory tract. American Journal of Surgical Pathology 1995; 19: 284–296
   PubMed Web of Science ®Google Scholar
• Kanavaros P., Lescs M. C., Briere J., Divine M., Galateau R, Joab I., Bosq J., Facet J. P., Reyes F., Gaulard P. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 1993; 81: 2688–2695
   PubMed Web of Science ®Google Scholar
• Bassan R., Rambaldi A., Allavena P., Abbate M., Marini B., Barbui T. Association of large granular lymphocyte/natural killer cell proliferative disease and second hema-tologic malignancy. American Journal of Hematology 1988; 29: 85–93
   PubMed Web of Science ®Google Scholar
• Ishida F., Saitoh H., Furihata K., Furuta S., Sonoyama M., Oshimi K. Granular lymphocyte leukemia of natural killer cell type: association with 47 XY,+8 by interleukin (IL-2)-stimulated chromosomal analysis. Rinsho Ketsueki 1990; 31: 1711–1715
   PubMedGoogle Scholar
• Okuda T., Sakamoto S., Deguchi T., Misawa S., Kashima K., Yoshihara T., Ikushima S., Hibi S., Imashuku S. Hemophagocytic syndrome associated with aggressive natural killer cell leukemia. American Journal of Hematology 1991; 38: 321–323
   PubMed Web of Science ®Google Scholar
• Hart D. N.J., Baker B. W., Inglis M. J., Starling G. C., Deacon E., Rowe M., Beard M. E.J. Epstein-Barr viral DNA in acute large granular lymphocyte (natural killer) leukemic cells. Blood 1992; 79: 2116–2123
   PubMed Web of Science ®Google Scholar
• Sun T., Schulman P., Kolitz J., Susin M., Brody J., Koduru P., Muuse W., Hombal S., Teichberg S., Broome J. A study of lymphoma of large granular lymphocytes with modem modalities: report of two cases and review of the literature. American Journal of Hematology 1992; 40: 135–145
   PubMed Web of Science ®Google Scholar
• Sun T., Brody J., Susin M., Marino J., Teichberg S., Hoduru P., Hall W., Urmacher C., Hajdu S. I. Aggressive natural killer cell lymphom/leukemia: a recently recognised clinicopathologic entity. Americna Journal of Surgical Pathology 1993; 17: 1289–1299
   PubMed Web of Science ®Google Scholar
• Oshirni K., Yamada O., Kaneko T., Nishinarita S., Lizuka Y., Urabe A., Inamori T., Asano S., Takhashi S., Hattori M., Naohara T., Ohira Y., Togawa A., Masuda Y., Okubo Y., Furusawa S., Sakamoto S., Omine M., Mori M., Tatsumi E., Mizoguchi H. Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders. Leukemia 1993; 7: 782–788
   PubMed Web of Science ®Google Scholar
• Nichols G. E., Normansell D. E., Williams M. E. Lymphoproliferative disorder of granular lymphocytes: nine cases including one with features of CD56 (NKH1)-positive aggressive natural killer cell lymphoma. Modem Pathology 1994; 7: 819–824
   PubMed Web of Science ®Google Scholar
• Ohnuma K., Toyoda Y., Nishihira H., Iguchi A., Honda K., Nagao T., Kigasawa H., Tanaka Y., Kikuta H. Aggressive natural killer (NK) cell lymphoma: report of a pediatric case and review of the literature. Leukemia and Lymphoma 1997; 25: 387–392
   PubMed Web of Science ®Google Scholar
• Callet-Bauchu E., Rimokh R., Gazzo S., Pages J., Bastion Y., Berger F., Coeur P., Felman P. Unbalanced X; automsome translocation (X;18)(q13;p11) in a case of aggressive natural killer non-Hodgkin lymphoma. Cancer Genetics and Cytogenetics 1997; 98: 16–19
   PubMed Web of Science ®Google Scholar
• Mateu R., Badell I., Alcala A., Estivill C., Rubiol E., Nomdedeu J., Soh J. Aggressive natural killer cell leukemia: report of a case in a Caucasian boy (Letter). Haematologica 1998; 83: 190–192
   PubMed Web of Science ®Google Scholar
• Xie M., Kovarik O., Le Beau M. M., Anastasi J. True NK cell lymphoma with blastic features, pseudo-rosette formation and translocation of 6q23 in a 9 year old patient (Abstr). 1998, Presented in the IX Meeting of the European Association of Haematopathology, Leiden, the Netherlands).
   Google Scholar
• Schouten H. C., Sanger W., Weisenburger D. D., Armitage J. O. Abnormalities involving chromosome 6 in newly diagnosed patients with non-Hodgkin's lymphoma. Cancer Genetics and Cytogenetics 1990; 47: 73–82
   PubMed Web of Science ®Google Scholar
• Offit K., Parsa N. Z., Gaidano G., Filippa D. A., Louie D., Pan D., Jhanwar S. C., Dalla-Favera R., Chaganti R. S.K. 6q deletions define distinct clinico-pathologic subsets of non-Hodgkin's lymphoma. Blood 1993; 82: 2157–2162
   PubMed Web of Science ®Google Scholar
• Gaidano G., Hauptschein R. S., Parsa N. Z., Offit K., Rao P. H., Lenoir G., Knowles D. M., Chaganti R. S.K., Dalla-Favera R. Deletions involving two distinct regions of 6q in B-cell non-Hodgkin lymphoma. Blood 1992; 80: 1781–1787
   PubMed Web of Science ®Google Scholar
• Merup M., Moreno T. C., Heyrnan M., Ronnberg K., Grander D., Detlofsson R., Rasool O., Liu Y., Soderhall S., Juliusson G., Gahrton G., Einhorn S. 6q deletions in acute lymphoblastic leukemia and non-Hodgkin's lymphomas. Blood 1998; 91: 3397–340
   PubMed Web of Science ®Google Scholar
• Takeuchi S., Koike M., Seriu T., Bartram C. R., Schrappe M., Reiter A., Park S., Taub H. E., Kubonishi I., Miyoshi I., Koeffler H. P. Frequent loss of heterozygosity on the long arm of chromosome 6: identification of two distinct regions of deletion in childhood acute lymphoblastic leukemia. Cancer Research 1998; 58: 2618–2623
   PubMed Web of Science ®Google Scholar
• Weber-Matthiesen K., Winkemann M., Muller-Hermelink A., Schlegelberger B., Grote W. Simultaneous fluorescence immunophenotyping and interphase cytogenetics: a contribution to the characterization of tumor cells. Journal of Histochemistry and Cytochemistry 1992; 40: 171–175
   PubMed Web of Science ®Google Scholar
• Johansson B., Mertens F., Mitelman F. Primary vs. secondary neoplasia-associated chromosomal abnormalities - balanced rearrangements vs. genomic imbalances?. Genes Chromosomes & Cancer 1996; 16: 155–163
   PubMed Web of Science ®Google Scholar
• Cheng R. Z., Guan X. Y., Lau G., Chan J. K.C., Trent J., Zhuang Z. P., Pack S., Raffeld M., Jaffe E. S. Chromosome 1p terminal deletion and loss of chromosome 17p and 16p are common findings in nasal NK/T cell lymphoma by comparative genomic hybridization (Abstract). Modem Pathology 1998; 11: 126A
   Web of Science ®Google Scholar